ABVC BIOPHARMA, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On March 5, 2025, Mr. Leeds Chow, the Chief Financial Officer (“CFO”) of ABVC BioPharma, Inc. (the “Company”) notified the Company of his resignation as CFO.
While the Company is looking for a full-time Chief Financial Officer to fill the vacancy created by Leeds Chow’s resignation, the Company’s CEO, Uttam Patil will serve as the interim Chief Financial Officer of the Company.
Extracted from this filing and checked against the source text.
Leeds Chow resigned as Chief Financial Officer at ABVC BIOPHARMA, INC..
On March 5, 2025, Mr. Leeds Chow, the Chief Financial Officer (“CFO”) of ABVC BioPharma, Inc. (the “Company”) notified the Company of his resignation as CFO.View on SEC.gov
Uttam Patil changed role as interim Chief Financial Officer at ABVC BIOPHARMA, INC..
While the Company is looking for a full-time Chief Financial Officer to fill the vacancy created by Leeds Chow’s resignation, the Company’s CEO, Uttam Patil will serve as the interim Chief Financial Officer of the Company.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.